RedHill Biopharma (RDHL) Receivables (2016 - 2025)
RedHill Biopharma's Receivables came in at $79 million for the quarter ended Dec 31, 2025, compared with $2.54 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Receivables (2016 - 2025) Analysis & Trends
Going back to the quarter ended Dec 31, 2016, RedHill Biopharma's Receivables data covers 31 quarters.
- Receivables carries a five-year compound annual growth rate of 22.5% (years ended Dec 2020 to Dec 2025).
- Going back by year, Receivables was $2.54 million in the year ended Dec 31, 2024 (-2.0%), $2.59 million in the year ended Dec 31, 2023 (-92.5%), $34.52 million in the year ended Dec 31, 2022 (+9.0%) and $31.68 million in the year ended Dec 31, 2021 (+10.5%).
- The figure for the quarter ended Dec 31, 2025 represents the highest quarterly Receivables in data going back to the quarter ended Dec 31, 2016.
- The fastest year-over-year change in Receivables over five years came in the quarter ended Jun 30, 2025 (growth of 449.3%), and the weakest in the quarter ended Dec 31, 2023 (a decline of 92.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn | 12.49 Bn |
| 10 | RedHill Biopharma | 1.47 Mn | -15.14 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 79,000.00 |
| Jun 30, 2025 | 5.35 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Jun 30, 2024 | 974,000.00 |
| Dec 31, 2023 | 2.59 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 6.85 Mn |
| Dec 31, 2022 | 34.52 Mn |
| Sep 30, 2022 | 36.01 Mn |
| Jun 30, 2022 | 33.76 Mn |
| Mar 31, 2022 | 25.93 Mn |
| Dec 31, 2021 | 31.68 Mn |
| Sep 30, 2021 | 30.04 Mn |
| Jun 30, 2021 | 30.10 Mn |
| Mar 31, 2021 | 23.31 Mn |
| Dec 31, 2020 | 28.66 Mn |
| Sep 30, 2020 | 12.42 Mn |
| Jun 30, 2020 | 18.57 Mn |
| Mar 31, 2020 | 1.72 Mn |
| Dec 31, 2019 | 1.22 Mn |
API Access
RedHill Biopharma Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();